Developer docs
API playgroundTry for free, no card

Search company profiles

Bionime

Full company profile

uuid000ffmx

Namestring
Bionime
Websiteurl
bionime.com
Company typeenum
Private
Founded yearint
2003
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersTaichung, Taiwan
HQ citystring
Taichung
HQ countrystring
Taiwan
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
blood glucose monitoring, biotechnology medical testing, diabetes care devices, medical device manufacturing, glucose meter products
Industry3 codes
PRIMARYHLAHAHAG
Blood Glucose Monitoring (BGM) Meters & Test Strips
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYCRACAQAE
Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHLAHAOAB
Blood Glucose & Metabolic POCT (Glucose, Ketones, Lactate)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
NAICS code2 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Blood Glucose Monitoring Devices
Social media profiles1 record
Cost components4 values
Supply Chain, Operations, Personnel, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Bionime designs, manufactures, and distributes blood glucose monitoring devices for diabetic patients who require regular glucose measurement and disease management. The company operates in the biotechnology and medical testing sector, producing diagnostic hardware used by individuals managing diabetes.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Blood Glucose Monitoring Devices
CategoryBlood Glucose Monitoring Devices
Description

Handheld blood glucose monitoring devices designed for diabetic patients who require regular glucose measurement for self-management of their condition. Sold to individual consumers managing diabetes.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Chinese blood glucose monitoring device manufacturer with similar scale and Asian manufacturing base; directly comparable mid-size BGM peer to Bionime.

TypeDirect peer
Description

US-based manufacturer of TRUE brand blood glucose meters and test strips, a comparable mid-size BGM specialist.

TypeBroad incumbent
Description

Manufactures the Accu-Chek line of blood glucose meters and test strips, a direct BGM competitor to Bionime, operating as part of Roche's much larger diagnostics portfolio.

TypeDirect peer
Description

OneTouch brand maker of blood glucose monitoring systems and consumables — a direct BGM peer competing for the same diabetic patient segment as Bionime.

TypeDirect peer
Description

Owns the CONTOUR blood glucose monitoring portfolio and competes head-to-head with Bionime in the BGM meters and strips category globally.

TypeBroad incumbent
Description

Sells FreeStyle Libre CGM and FreeStyle blood glucose meters, named alongside Bionime in the Saudi Arabia market and a benchmark global diabetes device competitor.

TypeBroad incumbent
Description

Leading CGM manufacturer explicitly identified as a competitor to Bionime in the Saudi market; competes for diabetes monitoring share with a different technology approach.

TypeBroad incumbent
Description

Major diabetes care player offering insulin pumps and BGM/CGM systems, named as a fellow competitor to Bionime in Saudi Arabia.

TypeDirect peer
Description

Manufacturer of point-of-care and self-monitoring blood glucose analyzers used in hospital and patient settings — overlaps with Bionime in glucose measurement technology.

TypeEmerging player
Description

Japanese diagnostics manufacturer of blood glucose meters and POCT devices for both consumer and clinical use, comparable in mid-sized BGM and POCT orientation.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bionime

Blood Glucose Monitoring Devicesbionime.com

Bionime firmographics

Firmographics
Name
Bionime
Website
https://bionime.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Bionime industry classification

Industry
Product category
Blood Glucose Monitoring Devices
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAHAG
Blood Glucose Monitoring (BGM) Meters & Test Strips
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYCRACAQAE
Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHLAHAOAB
Blood Glucose & Metabolic POCT (Glucose, Ketones, Lactate)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics

Keywords

  • Blood glucose monitoring
  • Biotechnology medical testing
  • Diabetes care devices
  • Medical device manufacturing
  • Glucose meter products

Where Bionime is headquartered

Location

Headquarters

HQ city
Taichung
HQ country
Taiwan
HQ region
Asia

Markets served

Bionime business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D

Bionime product offering

Product offering

Core offering

Bionime designs, manufactures, and distributes blood glucose monitoring devices for diabetic patients who require regular glucose measurement and disease management. The company operates in the biotechnology and medical testing sector, producing diagnostic hardware used by individuals managing diabetes.

Differentiator

Problem solved

Functional benefit

Products and services

  • Blood Glucose Monitoring Devices Handheld blood glucose monitoring devices designed for diabetic patients who require regular glucose measurement for self-management of their condition. Sold to individual consumers managing diabetes.

Companies that use Bionime

Customer profile

Segments1 record

Ideal customer profiles1 record

Bionime technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bionime partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves1 record

Expansion highlights3 records

Bionime competitors and assessment

Company assessment

Direct peers

  • Sinocare: Chinese blood glucose monitoring device manufacturer with similar scale and Asian manufacturing base; directly comparable mid-size BGM peer to Bionime.
  • Trividia Health: US-based manufacturer of TRUE brand blood glucose meters and test strips, a comparable mid-size BGM specialist.
  • LifeScan: OneTouch brand maker of blood glucose monitoring systems and consumables — a direct BGM peer competing for the same diabetic patient segment as Bionime.
  • Ascensia Diabetes Care: Owns the CONTOUR blood glucose monitoring portfolio and competes head-to-head with Bionime in the BGM meters and strips category globally.
  • Nova Biomedical: Manufacturer of point-of-care and self-monitoring blood glucose analyzers used in hospital and patient settings — overlaps with Bionime in glucose measurement technology.

Broad incumbents

  • Roche Diabetes Care: Manufactures the Accu-Chek line of blood glucose meters and test strips, a direct BGM competitor to Bionime, operating as part of Roche's much larger diagnostics portfolio.
  • Abbott Diabetes Care: Sells FreeStyle Libre CGM and FreeStyle blood glucose meters, named alongside Bionime in the Saudi Arabia market and a benchmark global diabetes device competitor.
  • Dexcom: Leading CGM manufacturer explicitly identified as a competitor to Bionime in the Saudi market; competes for diabetes monitoring share with a different technology approach.
  • Medtronic Diabetes: Major diabetes care player offering insulin pumps and BGM/CGM systems, named as a fellow competitor to Bionime in Saudi Arabia.

Emerging players

  • ARKRAY: Japanese diagnostics manufacturer of blood glucose meters and POCT devices for both consumer and clinical use, comparable in mid-sized BGM and POCT orientation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights5 records

Customer concentration

Bionime social profiles

Digital presence

Bionime financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bionime leadership team

Management profile

Number of profiles

Bionime funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bionime M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bionime

What does Bionime do?

Bionime designs, manufactures, and distributes blood glucose monitoring devices for diabetic patients who require regular glucose measurement and disease management. The company operates in the biotechnology and medical testing sector, producing diagnostic hardware used by individuals managing diabetes.

When was Bionime founded?

Bionime was founded in 2003. It employs 101 to 250 people.

Where is Bionime based?

Bionime is headquartered in Taichung, Taiwan, in the Asia region.

Who are Bionime's main competitors?

Direct peers on record are Sinocare, Trividia Health, LifeScan, Ascensia Diabetes Care and Nova Biomedical. Broad incumbents are Roche Diabetes Care, Abbott Diabetes Care, Dexcom and Medtronic Diabetes. ARKRAY is listed as an emerging player.

Does Bionime have an API?

No public API is recorded for Bionime.

What industry is Bionime in?

Bionime's product category is Blood Glucose Monitoring Devices. Its primary akta.pro industry code is HLAHAHAG, Blood Glucose Monitoring (BGM) Meters & Test Strips, with a secondary code of CRACAQAE, Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers). Its NAICS code is 3345 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooSaudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo NordiskResearchAndMarkets.com published a market research report projecting the Saudi Arabia blood glucose device market to grow from US$143.96 million in 2024 to US$259.8 million by 2033, at a CAGR of 6.78%. The report attributes growth to rising diabetes prevalence (affecting over 4.27 million individuals), government Vision 2030 health initiatives, and advances in CGM technology, while noting challenges including high device costs and limited rural access. Key market players analyzed include Abbott Laboratories, Medtronic, Dexcom Inc., and Novo Nordisk, among others.OracleEssential reading: Explaining modern data management (Part 3)The article highlights three companies—Lyft, Bionime, and Experian—that implemented Oracle data management solutions to improve their operational efficiency and analytics capabilities. Lyft utilized Oracle Autonomous Database to streamline financial reporting, while Bionime adopted MySQL HeatWave on AWS for faster glucose monitoring data processing. Experian migrated its workloads to Oracle Cloud Infrastructure, resulting in significant performance gains and cost reductions.PR NewswireU.S. Self-Testing Market to Surpass US$ 11.24 billion by 2028, Says Brandessence Market Research (BMRC)Brandessence Market Research published a report on the U.S. self-testing market, valued at US$ 12.6 billion in 2021 and projected to reach US$ 11.24 billion by 2028, reflecting a negative CAGR of -3.0%. Growth drivers include rising chronic disease prevalence, technological advancements, and increased e-commerce distribution, while concerns about unreliable results act as a restraint. The competitive landscape features Abbott Laboratories, Acon Laboratories Inc., Btnx Inc., Bionime Corporation, Roche Holding AG, Quidel Corporation, True Diagnostics Inc., Thermo Fisher Scientific, and Arkaray Inc.PR NewswireTaiwan Aims to Boost Sales in US Market with New Cost-Saving Medical DevicesFour Taiwanese medical device companies showcased new cost-saving products at the 2019 Florida International Medical Expo in Miami, including BenQ Materials Corp.'s SIMO Negative Pressure Wound Therapy system, Bionime Corporation's Rightest Care Diabetes Management app, MedicalTek's MonoStereo Visualization System, and Tronware MedTech's 3D microscopes. The products aim to reduce healthcare costs by enabling treatment outside traditional medical facilities, shortening hospital stays, and accelerating wound healing. Taiwan's trade promotion body TAITRA organized the event as part of efforts to boost Taiwanese medical device sales in the US market.PR NewswireLess Hospital Stays and More Healing-On-The-Go is New Trend with Medical Inventions from TaiwanTaiwanese companies BenQ, Bionime, MedicalTek, and Tronware MedTech are showcasing new medical devices at the FIME Show in Miami to promote healing-on-the-go solutions. These innovations include BenQ's portable wound therapy system, Bionime's diabetes management app, and advanced surgical visualization tools designed to reduce hospital stays and improve patient recovery.PR NewswireWorld Personal Use Self Monitoring Blood Glucose Market Report Featuring Abbott Diabetes Care, Roche, Johnson & Johnson, Arkray, Ascensia Diabetes Care, Agamatrix, Bionime, Acon, Trivida, & RossmaxResearch and Markets published a market report on the global personal-use self-monitoring blood glucose (SMBG) market, projecting growth through 2024 driven by rising diabetes prevalence and technological innovations in glucometers. The report finds that blood glucose test strips hold 77% of the market share due to their one-time-use nature requiring continuous repurchase, while North America leads with a projected 21.63% CAGR. The competitive landscape section profiles key manufacturers including Abbott Diabetes Care, Roche, Johnson & Johnson, Arkray, Ascensia Diabetes Care, Agamatrix, Bionime, Acon, Trivida, and Rossmax.